Case Reports in Neurological Medicine最新文献_第7页

Acute Peripheral Facial Paralysis Masquerading as Bell's Palsy Is the First Presentation of COVID-19 Infection. 伪装成贝尔麻痹的急性周围性面瘫是COVID-19感染的首次表现。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/4278146

Tabtim Chongsuvivatwong, Panitta Mueanchoo, Praewchompoo Sathirapanya, Pornchai Sathirapanya

{"title":"Acute Peripheral Facial Paralysis Masquerading as Bell's Palsy Is the First Presentation of COVID-19 Infection.","authors":"Tabtim Chongsuvivatwong, Panitta Mueanchoo, Praewchompoo Sathirapanya, Pornchai Sathirapanya","doi":"10.1155/2023/4278146","DOIUrl":"https://doi.org/10.1155/2023/4278146","url":null,"abstract":"Although Bell's palsy is a common diagnosis of acute isolated peripheral facial palsy (PFP), acute isolated PFP can be the first presentation of various illnesses, including COVID-19 disease. A female with a known history of well-controlled diabetes mellitus presented initially with acute isolated PFP mimicking Bell's palsy. A course of oral prednisolone was given to treat acute PFP. Severe fifth cervical radicular pain, which is unusual for Bell's palsy followed 3 days later. The COVID-19 infection was finally diagnosed by a real-time polymerase chain reaction (RT-PCR) test 15 days after facial paralysis when typical pulmonary infection symptoms developed. Oral favipiravir was given for the treatment of COVID-19 infection, to which the symptoms completely responded. The COVID-19 infection as a cause of acute isolated PFP should be added to the differential diagnosis of acute isolated PFP, albeit without typical pulmonary infection symptoms, particularly during the global pandemic of the infection.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":"2023 ","pages":"4278146"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10742045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS Syndrome): A Case Report and Literature Review. 慢性淋巴细胞炎症伴桥桥血管周围增强对类固醇反应(CLIPPERS综合征):1例报告和文献复习。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/5811243

Nripesh Man Shrestha, Niranjan Acharya, Rabindra Desar

引用次数: 0

Postanoxia-Induced Chorea Treated with Intravenous Fentanyl. 静脉注射芬太尼治疗脓毒性舞蹈病。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/7652013

Ashley Audi, Brittany Cunningham, Christopher Newey

引用次数: 0

Isolated Neurosarcoidosis Presenting as Chronic Progressive Pachymeningitis. 孤立性神经结节病表现为慢性进行性厚性脑膜炎。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/2140740

Joshua Abata, Danielle Bazer, Nicholas Koroneos, Olga Syritsyna

{"title":"Isolated Neurosarcoidosis Presenting as Chronic Progressive Pachymeningitis.","authors":"Joshua Abata, Danielle Bazer, Nicholas Koroneos, Olga Syritsyna","doi":"10.1155/2023/2140740","DOIUrl":"https://doi.org/10.1155/2023/2140740","url":null,"abstract":"Neurologic manifestations of sarcoidosis are rare, and even rarer still are cases of isolated neurosarcoidosis. The clinical presentation of isolated neurosarcoidosis can be highly variable, and diagnosis is particularly challenging, the gold standard being tissue biopsy. We describe a patient with a history of atypical parkinsonian syndrome and chronic right frontal lobe infarct who developed weakness, imbalance, and gait disequilibrium in 2008, with magnetic resonance imaging at that time showing leptomeningeal and nodular enhancements in the bilateral frontal and parietal lobes. The patient had an extensive negative workup in 2010 but ultimately did not receive a definitive diagnosis with a tissue biopsy until 2020. The patient also notably failed a 3-month course of steroids after his biopsy due to a lack of symptomatic improvement. This case highlights the clinical variability and diagnostic difficulties of isolated neurosarcoidosis. We also highlight that our patient did not have any symptomatic improvement on steroids, which do typically provide some relief for patients.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":"2023 ","pages":"2140740"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9143593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Encephalo-Arterio-Synangiosis with Cranioplasty after Treatment of Acute Subdural Hematoma Associated with Subcortical Hemorrhage Due to Unilateral Moyamoya Disease. 单侧烟雾病所致急性硬膜下血肿合并皮质下出血后脑动脉血管合并颅成形术治疗。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/1787738

Naoki Kato, Shota Kakizaki, Yusuke Hirokawa, Shotaro Michishita, Takuya Ishii, Tohru Terao, Yuichi Murayama

{"title":"Encephalo-Arterio-Synangiosis with Cranioplasty after Treatment of Acute Subdural Hematoma Associated with Subcortical Hemorrhage Due to Unilateral Moyamoya Disease.","authors":"Naoki Kato, Shota Kakizaki, Yusuke Hirokawa, Shotaro Michishita, Takuya Ishii, Tohru Terao, Yuichi Murayama","doi":"10.1155/2023/1787738","DOIUrl":"https://doi.org/10.1155/2023/1787738","url":null,"abstract":"Moyamoya disease is often diagnosed after intracranial hemorrhage in adult patients. Here, we report a case of unilateral moyamoya disease treated with indirect revascularization combined with cranioplasty after treatment for acute subdural hematoma and subcortical hemorrhage. A middle-aged woman with disturbed consciousness was transferred to our hospital. Computed tomography (CT) revealed an acute subdural hematoma with left temporoparietal subcortical hemorrhage. Three-dimensional CT angiography indicated a scarcely enhanced left middle cerebral artery (MCA) that was suspected to be delayed or nonfilling due to increased intracranial pressure. Subsequently, hematoma evacuation and external decompression were performed. Postoperative digital subtraction angiography (DSA) revealed stenosis of the left MCA and moyamoya vessels, indicating unilateral moyamoya disease. Forty-five days after the initial procedure, we performed encephalo-arterio-synangiosis (EAS) using the superficial temporal artery simultaneously with cranioplasty for the skull defect. The modified Rankin Scale score of the patient one year after discharge was 1, and the repeat DSA showed good patency of the EAS. Revascularization using EAS in the second step can be an option for revascularization for hemorrhagic moyamoya disease if the patient required cranioplasty for postoperative skull defect after decompressive craniotomy.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":"2023 ","pages":"1787738"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10625123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Something Got Your Tongue? A Unique Cause of Hypoglossal Nerve Palsy. 你说错话了?舌下神经麻痹的独特病因。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2022-11-22 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2884145

Alan Tesson, Peter Kranz, Ali Zomorodi, Joel Morgenlander

{"title":"Something Got Your Tongue? A Unique Cause of Hypoglossal Nerve Palsy.","authors":"Alan Tesson, Peter Kranz, Ali Zomorodi, Joel Morgenlander","doi":"10.1155/2022/2884145","DOIUrl":"https://doi.org/10.1155/2022/2884145","url":null,"abstract":"Introduction: The authors report a rare cause of isolated hypoglossal nerve palsy caused by a high cervical osteophyte. This case increases clinical knowledge of an underreported condition and teaches the clinician radiologic pearls in making the diagnosis. To their knowledge, this is the first case report showing surgical remediation of this condition. Symptoms and Clinical Findings. A 73-year-old female presented with several months of occipital headache, progressive dysarthria, dysphagia, and tongue deviation to the right. Her neurologic exam was significant for atrophy of the right hemitongue with tongue fasciculations. On protrusion, her tongue deviated rightward. Diagnosis and Therapeutic Intervention. Careful review of her initial head computed tomography (CT) imaging revealed that a high cervical osteophyte caused unilateral, isolated hypoglossal nerve palsy. Neurosurgery performed a right, far lateral approach for decompression of this osteophyte and over the ensuing months her symptoms improved.Conclusion: High cervical osteophyte is an underrecognized cause of isolated hypoglossal nerve palsy. The imaging investigation should be systematic and focus on the skull base with magnetic resonance imaging (MRI) or CT. This is a rare occasion when high resolution CT of the skull base can actually be the more helpful imaging modality. As shown in this case, an osteoarthritic cause can be surgically ameliorated.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":" ","pages":"2884145"},"PeriodicalIF":0.9,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40457534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Right Unilateral Spatial Neglect Improves with Intrinsic Motivation. 右单侧空间忽视随内在动机而改善。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4828549

Hirotaka Saito, Haruka Kobayashi, Junichi Yatsu, Shigeru Obayashi

{"title":"Right Unilateral Spatial Neglect Improves with Intrinsic Motivation.","authors":"Hirotaka Saito, Haruka Kobayashi, Junichi Yatsu, Shigeru Obayashi","doi":"10.1155/2022/4828549","DOIUrl":"https://doi.org/10.1155/2022/4828549","url":null,"abstract":"Background. In the acute phase of stroke, it is well known that the incidence and severity of unilateral spatial neglect (USN) are more significant in the right hemisphere injuries. Still, the detection of USN in left hemisphere injuries has been increasing in recent years. This trend is because behavioral assessments have prevented the exclusion of patients who are difficult to assess for USN or apathy using conventional paper-and-pencil tests (e.g., aphasia). Right USN and post-stroke apathy share many common lesions. Therefore, clinical symptoms may overlap, but little validation considers this. Case Study. A man (62 years old) determined to have the right USN and apathy was treated for six weeks in 3 terms. In the first term (weeks 1 to 2), the patient was treated for the right USN by conventional therapy. In the second term (3-4 weeks), treatment for right USN and apathy by goal-directed therapy based on affinity behavior was implemented. In the third term (5-6 weeks), goal-directed therapy based on affinity behavior was discontinued, and treatment was returned to conventional therapy only. In the second term (goal-directed therapy based on affinity behavior), the improvement in patients' apathy (clinical assessment for spontaneity) was more significant than the effect size in the third term (conventional therapy). There were no significant differences in USN (catherine bergego scale) and intrinsic motivation (pittsburgh rehabilitation participation scale). However, the effect size in the second term tended to be larger than in the third term (conventional therapy). Clinical Rehabilitation Impact. This report aims to demonstrate the limitations of current treatment for cases determined to have both right USN and apathy. Second, to assess the extent to which this new intervention can complement the limitations of current treatment.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":" ","pages":"4828549"},"PeriodicalIF":0.9,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40685275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Guillain-Barré Syndrome Associated with COVID-19 in a Japanese Male. 一名日本男性与COVID-19相关的格林-巴罗综合征

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2022-10-22 eCollection Date: 2022-01-01 DOI: 10.1155/2022/6837851

Yoshiki Esa, Yuta Kajiyama, Misako Kaido, Yushi Watanabe, Harutoshi Fujimura, Iwao Gohma, Kenichi Takahashi, Junya Kobayashi

{"title":"Guillain-Barré Syndrome Associated with COVID-19 in a Japanese Male.","authors":"Yoshiki Esa, Yuta Kajiyama, Misako Kaido, Yushi Watanabe, Harutoshi Fujimura, Iwao Gohma, Kenichi Takahashi, Junya Kobayashi","doi":"10.1155/2022/6837851","DOIUrl":"https://doi.org/10.1155/2022/6837851","url":null,"abstract":"April 2021 saw a widespread outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Osaka, Japan. We encountered the case of a 52-year-old man who had Guillain-Barré syndrome associated with coronavirus disease 2019 (COVID-19). After the relief of the respiratory symptoms owing to COVID-19, the patient experienced muscle weakness, which spread from his fingers to his extremities, and was unable to walk. Further examinations revealed mild protein elevation in the cerebrospinal fluid. In addition, nerve conduction studies showed demyelinating polyneuropathy, leading to the diagnosis of Guillain-Barré syndrome. After the administration of intravenous immunoglobulin and intravenous methylprednisolone, his symptoms drastically improved, and he was able to walk unaided 21 days after the onset of symptoms. On day 40, the patient was discharged with minimal muscle fatigue. Because Guillain-Barré syndrome associated with COVID-19 is expected to have a good prognosis, early diagnosis and treatment are important. Therefore, Guillain-Barré syndrome should be considered as a possible factor for muscle weakness during and after COVID-19 treatment.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":" ","pages":"6837851"},"PeriodicalIF":0.9,"publicationDate":"2022-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Serologic Presentation of Lamotrigine-Induced Lupus. 拉莫三嗪致狼疮的血清学表现。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2022-09-29 eCollection Date: 2022-01-01 DOI: 10.1155/2022/8756308

Hannah Dempsey, Gabriella Aitcheson, Gretchen Goble, Riley Snook

{"title":"Serologic Presentation of Lamotrigine-Induced Lupus.","authors":"Hannah Dempsey, Gabriella Aitcheson, Gretchen Goble, Riley Snook","doi":"10.1155/2022/8756308","DOIUrl":"https://doi.org/10.1155/2022/8756308","url":null,"abstract":"This paper discusses the presentation of a rare drug side effect, a case of drug-induced lupus presenting with weight loss, weakness, hepatitis, and pancreatitis. A 24-year-old male with a history of major depressive disorder and childhood seizures presented to the ER with symptoms of abdominal pain, significant weight loss, and weakness. Initial workup revealed acute pancreatitis, elevated liver function enzymes (LFTs), and abnormal anti-double-stranded DNA antibody (anti-dsDNA) 1 : 640. He showed no classical clinical signs of lupus including rash, arthritis, or photosensitivity. He had multiple hospitalizations in the previous 6 months for excessive weight loss, malnutrition, weakness, and altered mental status. He had been taking lamotrigine for seizure prevention and mood stabilization while on a selective serotonin reuptake inhibitor (SSRI) and had a decline in health since the lamotrigine dose was increased. Antihistone antibodies were positive suggesting a drug-induced lupus syndrome. We hope to bring awareness to the possible rare complication of lamotrigine-induced lupus.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":" ","pages":"8756308"},"PeriodicalIF":0.9,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33495138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Long-Lasting Unruptured Large Intracranial Aneurysm in Bilateral Moyamoya Disease: Case Report. 双侧烟雾病长期未破裂大颅内动脉瘤1例。

IF 0.9

Case Reports in Neurological Medicine Pub Date : 2022-09-19 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2635724

Eunyoung Chae, Soomin Jeong, Chan-Hyuk Lee

{"title":"Long-Lasting Unruptured Large Intracranial Aneurysm in Bilateral Moyamoya Disease: Case Report.","authors":"Eunyoung Chae, Soomin Jeong, Chan-Hyuk Lee","doi":"10.1155/2022/2635724","DOIUrl":"https://doi.org/10.1155/2022/2635724","url":null,"abstract":"Introduction: The rupture risk of intracranial aneurysms in patients with moyamoya disease is higher than that in the general population. We report a confirmed case of moyamoya disease with bilateral middle cerebral artery (MCA) occlusion with a large and long-lasting aneurysm.Case: A 71-year-old woman visited the clinic with a large intracranial aneurysm. The patient was diagnosed with an ischemic stroke 2 months ago. She exhibited weakness in the left upper and lower extremities and dysarthria and was taking aspirin. The brain magnetic resonance imaging showed complete occlusion in the bilateral MCA proximal (M1) and a large 11 × 11 mm nonruptured cerebral aneurysm in the A3 segment of the left anterior cerebral artery. On transfemoral cerebral angiography, the patient was diagnosed with Suzuki grade VI moyamoya disease with bilateral MCA occlusion. After 7 years, the cerebral aneurysm size further increased, but it remained unruptured.Conclusions: Here, the patient had moyamoya disease with a large aneurysm, but aneurysmal rupture did not occur even after 7 years. Our case report might help in understanding the mechanisms of cerebral aneurysm occurrence and rupture in moyamoya patients.","PeriodicalId":9615,"journal":{"name":"Case Reports in Neurological Medicine","volume":" ","pages":"2635724"},"PeriodicalIF":0.9,"publicationDate":"2022-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33514210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0